Lindsey O. Webster

2.1k citations

14 papers · 1.7k indexed · 1 hit paper · h-index 11

Oncology top 2%
Pediatrics, Perinatology and Child Health top 2%
Molecular Biology
Infectious Diseases top 5%
Pharmacology top 1%

Co-authors: Joseph W. Polli Joan E. Humphreys Stephen A. Wring Cosette J. Serabjit‐Singh James P. Morgan Lili Huang Kimberly K. Adkison John P. Keogh
Topics: Drug Transport and Resistance Mechanisms (9 papers)Pharmacological Effects and Toxicity Studies (5 papers)HIV/AIDS drug development and treatment (5 papers)
Cited by: Oncology Pharmacology Pediatrics, Perinatology and Child Health
Journals: Neurology Antimicrobial Agents and Chemotherapy Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Lindsey O. Webster

14 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery

2001 545 citations Joseph W. Polli, Stephen A. Wring et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers

Countries citing papers authored by Lindsey O. Webster

Since Specialization

Citations

This map shows the geographic impact of Lindsey O. Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsey O. Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsey O. Webster more than expected).

Fields of papers citing papers by Lindsey O. Webster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsey O. Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsey O. Webster. The network helps show where Lindsey O. Webster may publish in the future.

Co-authorship network of co-authors of Lindsey O. Webster

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsey O. Webster. A scholar is included among the top collaborators of Lindsey O. Webster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsey O. Webster. Lindsey O. Webster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	A Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy Participants 2021 ·Antimicrobial Agents and Chemotherapy ·Teodora Pene Dumitrescu,Samit R. Joshi,(unknown),(unknown),Mark Johnson,(unknown),Eric I. Zimmerman,Lindsey O. Webster,(unknown),Max Lataillade,Sherene Min	12
2	Phase I evaluation of pharmacokinetics and tolerability of the HIV‐1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults 2021 ·British Journal of Clinical Pharmacology ·Teodora Pene Dumitrescu,Samit R. Joshi,(unknown),Thomas Greene,Mark Johnson,(unknown),Eric I. Zimmerman,Lindsey O. Webster,(unknown),Max Lataillade,Sherene Min	10
3	Lack of pharmacokinetic interaction between the HIV‐1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women 2021 ·British Journal of Clinical Pharmacology ·Teodora Pene Dumitrescu,Thomas Greene,Samit R. Joshi,(unknown),Mark Johnson,(unknown),(unknown),Eric I. Zimmerman,Lindsey O. Webster,(unknown),Max Lataillade,Sherene Min	6
4	RVT-1401, A Novel Anti-FcRn Monoclonal Antibody, Is Well Tolerated in Healthy Subjects and Reduces Plasma IgG Following Subcutaneous or Intravenous Administration (P5.2-079) 2019 ·Neurology ·(unknown),(unknown),(unknown),Éric Sicard,Paul Griffin,Lindsey O. Webster,Regan Fong,Christine M. Coquery,Stephen C. Piscitelli	25
5	Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment fromin vitrostudies and a clinical investigation with midazolam 2015 ·Xenobiotica ·Melinda J. Reese,Gary D. Bowers,Joan E. Humphreys,Elizabeth Gould,Susan L. Ford,Lindsey O. Webster,Joseph W. Polli	42
6	Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast–enhanced Magnetic Resonance Imaging 2015 ·Toxicologic Pathology ·Stephen C. Lenhard,(unknown),Lindsey O. Webster,Richard A. Peterson,Chris N. Goulbourne,Richard T. Miller,Beat M. Jucker	5
7	In Vitro Investigations into the Roles of Drug Transporters and Metabolizing Enzymes in the Disposition and Drug Interactions of Dolutegravir, a HIV Integrase Inhibitor 2012 ·Drug Metabolism and Disposition ·Melinda J. Reese,Paul Savina,Grant T. Generaux,(unknown),Joan E. Humphreys,Eri Kanaoka,Lindsey O. Webster,Kelly A. Harmon,James Clarke,Joseph W. Polli	212
8	Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport 2009 ·Toxicology in Vitro ·Kristina Wolf,(unknown),Lindsey O. Webster,Grant T. Generaux,Joseph W. Polli,Kim L. R. Brouwer	35
9	IN VITRO P-GLYCOPROTEIN INHIBITION ASSAYS FOR ASSESSMENT OF CLINICAL DRUG INTERACTION POTENTIAL OF NEW DRUG CANDIDATES: A RECOMMENDATION FOR PROBE SUBSTRATES 2006 ·Drug Metabolism and Disposition ·Jarkko Rautio,Joan E. Humphreys,Lindsey O. Webster,Anand Balakrishnan,John P. Keogh,Jeevan Kunta,Cosette J. Serabjit‐Singh,Joseph W. Polli	222
10	Temporal kinetics and concentration–response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes 2006 ·Journal of Biochemical and Molecular Toxicology ·Richard Graham,(unknown),Wojciech Król,(unknown),Lindsey O. Webster,(unknown),Liangfu Chen,(unknown),Edward L. LeCluyse	18
11	MULTIPLE MECHANISMS ARE INVOLVED IN THE BILIARY EXCRETION OF ACETAMINOPHEN SULFATE IN THE RAT: ROLE OF MRP2 AND BCRP1 2005 ·Drug Metabolism and Disposition ·Maciej J. Zamek‐Gliszczynski,Keith Hoffmaster,Xianbin Tian,(unknown),Joseph W. Polli,Joan E. Humphreys,Lindsey O. Webster,Arlene S. Bridges,J. Cory Kalvass,Kim L. R. Brouwer	54
12	THE SYSTEMIC EXPOSURE OF AN N-METHYL-d-ASPARTATE RECEPTOR ANTAGONIST IS LIMITED IN MICE BY THE P-GLYCOPROTEIN AND BREAST CANCER RESISTANCE PROTEIN EFFLUX TRANSPORTERS 2004 ·Drug Metabolism and Disposition ·Joseph W. Polli,Todd M. Baughman,Joan E. Humphreys,(unknown),(unknown),Lindsey O. Webster,Robert J. Barnaby,Giovanni Vitulli,(unknown),Kevin D. Read,Cosette J. Serabjit‐Singh	20
13	Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs 2002 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown),Joan E. Humphreys,Lindsey O. Webster,Stephen A. Wring,(unknown),Cosette J. Serabjit‐Singh,Kimberly K. Adkison,Joseph W. Polli	458
14	Rational Use of in Vitro P-glycoprotein Assays in Drug Discoverybreakdown → 2001 ·Journal of Pharmacology and Experimental Therapeutics ·Joseph W. Polli,Stephen A. Wring,Joan E. Humphreys,Lili Huang,James P. Morgan,Lindsey O. Webster,(unknown)	545

About Lindsey O. Webster

Lindsey O. Webster is a scholar working on Pharmacology, Virology and Oncology, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (5 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Oncology (1.0k citations), Pharmacology (321 citations) and Pediatrics, Perinatology and Child Health (555 citations). Lindsey O. Webster has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Joseph W. Polli, Joan E. Humphreys, Stephen A. Wring, Cosette J. Serabjit‐Singh, James P. Morgan, Lili Huang, Kimberly K. Adkison, John P. Keogh, Jeevan Kunta and Anand Balakrishnan. Their work appears in journals such as Neurology, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact